Details of the Drug

General Information of Drug (ID: DMMCSJL)

• Drug Name: Autologous myoblast cell therapy
• Synonyms: Autologous myoblast cell therapy (myocardial infarction); FB-1001; Autologous myoblast cell therapy (myocardial infarction), Fina Biotech

Indication

Disease Entry	ICD 11	Status	REF
Myocardial infarction	BA41-BA43	Phase 2	[1]

• Cross-matching ID: TTD ID: D0B2XS

References

• [1] Clinical pipeline report, company report or official report of Fina Biotech Slu.